Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

6 Stock Charts To Watch: ACM, CRSP, FOLD, IOVA, LK, QURE

Published 06/18/2019, 01:59 AM
Updated 07/09/2023, 06:31 AM

It was an interesting day on Wall Street on Monday. A lot of stocks we follow ran, and the market had a wonderful day. It was a kind of bullish consolidation day. So, let’s take a look at a few we highlighted here.

AECOM (ACM)

Aecom Technology Corporation (NYSE:ACM) which is a large infrastructure firm, has been in a downtrend since the beginning of 2018, having dropped from 40 down to 25, and then at the end of Dec, it formed a V-bottom, platformed, ramped up in multiple waves up, and then made a breakaway move, spiking 1.77, or 5.3%, to 35.17, on 2.8 million shares. The key to Monday’s breakaway action is big volume through key resistance, and through the neckline. It looks like now, with an inverse head-and-shoulders, it could lead to 37 1/2, and then 40. Those are my targets.

CRISPR Therapeutics AG (CRSP)

Crispr Therapeutics AG (NASDAQ:CRSP) one of our swing trades, popped out of the wedge we were looking at the past week, did a 3.80 advance on 8% to 47.07, on nearly a million shares on Monday. It looks like the inverse head-and-shoulders-type basing pattern is completed. The next targets are 54, 60, and 67.

Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics Inc (NASDAQ:FOLD) looks like it has a V-bottom with a right hand extended, it held, and then on Monday it had a gain of 71 cents, or 6.26%, to 12.06, on 3.5 million shares. It’s picking up volume and looks like it may try to make a move. If it gets above 12.35-.40, it may run as high as 13 3/4 and 14, or better.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Iovance Biotherapeutics, Inc. (IOVA)

Iovance Biotherapeutics Inc (NASDAQ:IOVA) continues to pop. I gave you a buy, it pulled back and coiled for six weeks, and then exploded and has been ramping ever since, running 2.85, or 15%, to 21.95, on 3.8 million shares on Monday. The all-time high, for me, is 18, and Monday’s high was 22. I think it has more to go, but you have to be careful in here, because the angle of ascent is so steep that at any point it could pull back, but my target is in the mid 20’s.

Luckin Coffee Inc. (LK)

Luckin Coffee (NASDAQ:LK) a good Chinese growth coffee, and recent IPO, with a V-bottom, and a plunge, exploded for two days now. On Monday it was up 1.94 or 10%, to 21.17, on 7.9 million shares. Look for this to extend to 22.90. If it gets through that, we’ll look for a retest of the high at 26, or better.

uniQure N.V. (QURE)

Uniqure NV (NASDAQ:QURE) popped out and broke out and ran 8.59, or 12%, to 81.14, on 3.4 million shares on Monday. The volume hasn’t been this big since Feb when it exploded. I think it will go higher. My targets are 100, and then 112.

Stocks on the long side

AECOM (ACM), ArQule, Inc. (ARQL), Beyond Meat, Inc. (BYND), CRISPR Therapeutics AG (CRSP), Amicus Therapeutics, Inc. (FOLD), Bitcoin Investment Trust (GBTC), Incyte Corporation (NASDAQ:INCY), Iovance Biotherapeutics, Inc. (IOVA), Intra-Cellular Therapies, Inc. (ITCI), Keurig Dr Pepper Inc. (NYSE:KDP), the Direxion Daily S&P Biotech Bull 3X ETF (LABU), Luckin Coffee Inc. (LK), Lyft, Inc. (NASDAQ:LYFT), MoneyGram International, Inc. (MGI), Mimecast Limited (MIME), Mirati Therapeutics, Inc. (MRTX), uniQure N.V. (QURE), REGENXBIO Inc. (RGNX), Syndax Pharmaceuticals, Inc. (SNDX), Soliton, Inc. (SOLY), UP Fintech Holding Limited (TIGR), Voyager Therapeutics, Inc. (VYGR), Intrexon Corporation (XON), and ZIOPHARM Oncology, Inc. (ZIOP).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Watch Video Here

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.